125 related articles for article (PubMed ID: 19737309)
21. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
[TBL] [Abstract][Full Text] [Related]
22. Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease.
Hatzimichael E; Dranitsaris G; Dasoula A; Benetatos L; Stebbing J; Crook T; Bourantas KL
Clin Lymphoma Myeloma; 2009 Jun; 9(3):239-42. PubMed ID: 19525194
[TBL] [Abstract][Full Text] [Related]
23. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma.
Agrelo R; Setien F; Espada J; Artiga MJ; Rodriguez M; Pérez-Rosado A; Sanchez-Aguilera A; Fraga MF; Piris MA; Esteller M
J Clin Oncol; 2005 Jun; 23(17):3940-7. PubMed ID: 15867203
[TBL] [Abstract][Full Text] [Related]
25. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
26. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
27. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
[TBL] [Abstract][Full Text] [Related]
29. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene.
Pescador N; Cuevas Y; Naranjo S; Alcaide M; Villar D; Landázuri MO; Del Peso L
Biochem J; 2005 Aug; 390(Pt 1):189-97. PubMed ID: 15823097
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of multiple genes in astrocytic gliomas.
Gonzalez-Gomez P; Bello MJ; Arjona D; Lomas J; Alonso ME; De Campos JM; Vaquero J; Isla A; Gutierrez M; Rey JA
Int J Oncol; 2003 Mar; 22(3):601-8. PubMed ID: 12579314
[TBL] [Abstract][Full Text] [Related]
31. Mammalian EGLN genes have distinct patterns of mRNA expression and regulation.
Lieb ME; Menzies K; Moschella MC; Ni R; Taubman MB
Biochem Cell Biol; 2002; 80(4):421-6. PubMed ID: 12234095
[TBL] [Abstract][Full Text] [Related]
32. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway.
Fu J; Taubman MB
J Biol Chem; 2010 Mar; 285(12):8927-35. PubMed ID: 20089853
[TBL] [Abstract][Full Text] [Related]
33. hMLH1 and MGMT inactivation as a mechanism of tumorigenesis in monoclonal gammopathies.
Martin P; Santón A; García-Cosio M; Bellas C
Mod Pathol; 2006 Jul; 19(7):914-21. PubMed ID: 16607377
[TBL] [Abstract][Full Text] [Related]
34. Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma.
Ogmundsdóttir HM; Einarsdóttir HK; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma; 2009 Mar; 9(1):27-9. PubMed ID: 19362965
[TBL] [Abstract][Full Text] [Related]
35. p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.
Mateos MV; Garcia-Sanz R; López-Pérez R; Balanzategui A; González MI; Fernández-Calvo J; Moro MJ; Hernández J; Caballero MD; González M; San Miguel JF
Hematol J; 2001; 2(3):146-9. PubMed ID: 11920239
[TBL] [Abstract][Full Text] [Related]
36. Glutathione S-transferase P1 mRNA expression in plasma cell disorders and its correlation with polymorphic variants and clinical outcome.
Stella F; Weich N; Panero J; Fantl DB; Schutz N; Fundia AF; Slavutsky I
Cancer Epidemiol; 2013 Oct; 37(5):671-4. PubMed ID: 23953887
[TBL] [Abstract][Full Text] [Related]
37. Familial paraproteinemia: hyper-responsive B-cells as endophenotype.
Ögmundsdóttir HM; Steingrímsdóttir H; Haraldsdóttir V
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):82-4. PubMed ID: 21454198
[TBL] [Abstract][Full Text] [Related]
38. EGLN3 inhibition of NF-κB is mediated by prolyl hydroxylase-independent inhibition of IκB kinase γ ubiquitination.
Fu J; Taubman MB
Mol Cell Biol; 2013 Aug; 33(15):3050-61. PubMed ID: 23732909
[TBL] [Abstract][Full Text] [Related]
39. The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma.
Hatzimichael E; Lo Nigro C; Lattanzio L; Syed N; Shah R; Dasoula A; Janczar K; Vivenza D; Monteverde M; Merlano M; Papoudou-Bai A; Bai M; Schmid P; Stebbing J; Bower M; Dyer MJ; Karran LE; ElguetaKarstegl C; Farrell PJ; Thompson A; Briasoulis E; Crook T
Br J Cancer; 2012 Oct; 107(8):1423-32. PubMed ID: 22955849
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic silencing of EVL/miR-342 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chng WJ; Chim CS
Transl Res; 2018 Feb; 192():46-53. PubMed ID: 29242101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]